Meanwhile, the expression of SPP1 was positively correlated with the number of M2 macrophages, suggesting that treatment targeting SPP1 may be a potential therapeutic option to improve the prognosis of HCC patients. The gene discussed is SPP1; the disease is hepatocellular carcinoma.